Can Hormonal Contraception Influence Plasma Levels of IGF-1 andIGFBP-1 in Gracile Women With PCOS?
Authors:
G. Šindelka; D. Cibula; M. Fanta; Z. Kasalová; V. Justová; Z. Lacinová; J. Škrha
Authors‘ workplace:
III. interní klinika 1. LF UK a VFN, Praha Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha
Published in:
Čas. Lék. čes. 2001; : 469-472
Category:
Overview
Background.
Polycystic ovary syndrome (PCOS) represents a frequent endocrinopathy among fertile women.Ethiopathogenesis of the syndrome is multifactorial and it is a subject of scientific discussions. Considered is thepossibility of intraovarial IGF system disorder affecting maturation of ovarial folicles. The aim of our work was todetermine effects of peroral contraceptives with low-androgen progestin on IGF system in PCOS patients and healthywoman controls.Methods and Results. 14 patients fulfilling diagnostic criteria of PCOS and 7 healthy controls were included intothe study. All persons were examined before and after six months lasting administration of monophasic estrogen--progesteron contraceptive therapy with 35 mg of ethinylestradiol per day and 250 mg of low-androgen progestinnorgestimate per day. In PCOS patients low increase of basal insulinemia levels occurred (16.3±4.8 vs. 20.8±4.8 mU.l-1, p
Key words:
polycystic ovary syndrome, IGF, insulinemia.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Metabolic Disorders at Inflammatory Bowel Diseases
- Molecular Diagnosis of Rett Syndrome: Detection of the Prevalent Mutationsin MeCP2 Gene
- The Antiphospholipid Syndrome and Antiphospholipid Antibodies
- Reproductive Medicine from Childhood to Adulthood